75 related articles for article (PubMed ID: 924346)
1. Heterogeneity of extractable gut glucagon-like immunoreactivity (GLI) and its lipolytic activity.
Horigome K; Oneda A; Maruhama Y; Abe R; Kai Y
Horm Metab Res; 1977 Sep; 9(5):370-4. PubMed ID: 924346
[TBL] [Abstract][Full Text] [Related]
2. Purification of canine gut glucagon-like immunoreactivity (GLI) and its insulin releasing activity.
Ohneda A; Horigome K; Kai Y; Itabashi H; Ishii S; Yamagata S
Horm Metab Res; 1976 May; 8(3):170-4. PubMed ID: 939462
[TBL] [Abstract][Full Text] [Related]
3. A possible role for gut GLI: an inhibitor of lipolysis.
Krug E; Mialhe P
Horm Metab Res; 1977 Nov; 9(6):465-9. PubMed ID: 590920
[TBL] [Abstract][Full Text] [Related]
4. Antilipolytic nature of gut GLI, and mode of action of two highly potent intestinal lipolytic species in birds.
Krug E
Horm Metab Res; 1978 Nov; 10(6):505-9. PubMed ID: 217810
[TBL] [Abstract][Full Text] [Related]
5. Plasma glucagon-like immunoreactivity (GLI) in dogs.
Oneda A; Horigome K; Yanbe A; Ishii S; Itabashi H
Tohoku J Exp Med; 1975 Apr; 115(4):337-43. PubMed ID: 1145615
[TBL] [Abstract][Full Text] [Related]
6. The contribution of the pancreas and the intestine to the regulation of lipolysis in birds. I. Existence of highly potent lipolytic factors in ileum extracts.
Krug E; Mialhe P
Horm Metab Res; 1975 Jul; 7(4):305-9. PubMed ID: 1150130
[TBL] [Abstract][Full Text] [Related]
7. Identical biological effects of pancreatic glucagon and a purified moiety of canine gastric immunoreactive glucagon.
Doi K; Prentki M; Yip C; Muller WA; Jeanrenaud B; Vranic M
J Clin Invest; 1979 Mar; 63(3):525-31. PubMed ID: 429572
[TBL] [Abstract][Full Text] [Related]
8. A lipolytic factor from the submaxillary salivary glands of the rat.
Zimowska-Modelewska U
Acta Physiol Pol; 1984; 35(1):15-22. PubMed ID: 6099957
[TBL] [Abstract][Full Text] [Related]
9. Chromatographic pattern of gut glucagon-like immunoreactivity (GLI) in plasma before and during glucose absorption.
Valverde I; Ghiglione M; Matesanz R; Casado S
Horm Metab Res; 1979 May; 11(5):343-6. PubMed ID: 478429
[TBL] [Abstract][Full Text] [Related]
10. The use of perfused rat intestine to characterise the glucagon-like immunoreactivity released into serosal secretions following stimulation by glucose.
O'Connor FA; Conlon JM; Buchanan KD; Murphy RF
Horm Metab Res; 1979 Jan; 11(1):19-23. PubMed ID: 428905
[TBL] [Abstract][Full Text] [Related]
11. Absence of in vitro dexamethasone-dependent lipolytic activity from highly purified growth hormone.
Frigeri LG
Endocrinology; 1980 Sep; 107(3):738-43. PubMed ID: 7398577
[TBL] [Abstract][Full Text] [Related]
12. Specific biologic effects of intestinal glucagon-like materials.
Gutman RA; Fink G; Voyles N; Selawry H; Penhos JC; Lepp A; Recant L
J Clin Invest; 1973 May; 52(5):1165-75. PubMed ID: 4349485
[TBL] [Abstract][Full Text] [Related]
13. The effect of calcium and other salts upon the release of glucagon-like immunoreactivity from the gut.
Böttger I; Faloona GR; Unger RH
J Clin Invest; 1972 Apr; 51(4):831-6. PubMed ID: 5014613
[TBL] [Abstract][Full Text] [Related]
14. The contribution of the pancreas and the intestine to the regulation of lipolysis in birds. 2. Impaired lipolytic activity of pancreatic glucagon in the absence of either the pancreas or the intestine in the chicken.
Krug E; Gross R; Mialhe P
Horm Metab Res; 1976 Sep; 8(5):345-50. PubMed ID: 976934
[TBL] [Abstract][Full Text] [Related]
15. Renal metabolism of gut glucagon-like immunoreactivity.
Rovira A; López-Novoa JM; Zubiaur M; Matesanz R; Ghiglione M; Pascual JM; Valverde I
Endocrinology; 1982 Jun; 110(6):2030-6. PubMed ID: 6896180
[TBL] [Abstract][Full Text] [Related]
16. Lipolysis and cyclic-3', 5'-AMP content in rat adipose tissue at different age.
Macho L; Kolena J
Endocrinol Exp; 1975 Jun; 9(2):93-9. PubMed ID: 165056
[TBL] [Abstract][Full Text] [Related]
17. Characterization of response of gut GLI to fat ingestion in dogs.
Ohneda A; Kobayashi T; Nihei J
Horm Metab Res; 1984 Dec; 16 Suppl 1():105-9. PubMed ID: 6398248
[TBL] [Abstract][Full Text] [Related]
18. Studies on the interaction between growth hormone and dihydroergotamine in adipose cells. I. The lipolytic effect of dihydroergotamine.
Hotta N; Sirek OV; Sirek A
Horm Metab Res; 1971 May; 3(3):161-6. PubMed ID: 4399382
[No Abstract] [Full Text] [Related]
19. Gut glucagon, enteroglucagon, gut glucagonlike immunoreactivity, glicentin--current status.
Holst JJ
Gastroenterology; 1983 Jun; 84(6):1602-13. PubMed ID: 6188645
[TBL] [Abstract][Full Text] [Related]
20. Boiling method for the extraction of gut glucagon-like immunoreactive materials.
Tanaka R; Shima K; Tarui S; Nishikawa M
Endocrinol Jpn; 1975 Dec; 22(6):503-7. PubMed ID: 1231992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
